Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and p...
Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease behaviour and outcome.
In total 74 adult ISM patients who were followed for ≥48 months and received no cytoreduct...
Alternative Titles
Full title
Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1441865871
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1441865871
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0076116
